Canada markets closed

NeutriSci International Inc. (NRXCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1061+0.0057 (+5.72%)
At close: 12:43PM EDT

NeutriSci International Inc.

4015 - 1st Street SE
Suite #1A
Calgary, AB T2G 4X7
Canada
403 264 6320
http://www.neutrisci.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Glen RehmanCEO, Pres & DirectorN/AN/AN/A
Mr. John Robert ChisholmChief Financial OfficerN/AN/A1962
Mr. Thierry SorhaitzVP of Sales & MarketingN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada. Its products include Neuenergy, an energy chewable tablet that provides focus and mental clarity; and BluScience, a nutraceutical product. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with Cryopharm Corporation and Nutritional High International Inc. NeutriSci International Inc. was founded in 2009 and is headquartered in Calgary, Canada.

Corporate Governance

NeutriSci International Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.